Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2007-02-16
2011-10-11
Kemmerer, Elizabeth C (Department: 1649)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S185100, C424S190100, C424S245100, C424S247100, C424S248100, C536S023400
Reexamination Certificate
active
08034353
ABSTRACT:
An object of the present invention is to provide a peptide vaccine for preventing and/or treating diseases caused by amyloid β-peptide, such as Alzheimer's disease. The present invention solves the above object by providing a peptide vaccine constructed by inserting a peptide having an amino acid sequence of a cell attachment motif of a cell adhesive molecule to a peptide which consists of a peptide having an amino acid sequence of multiagretope type T-cell epitope, which has been generated immunological memory, or a peptide including the same; an linker peptide; and a peptide having an amino acid sequence of a B cell epitope which is a specific region of amyloid β-peptide or a peptide including the same.
REFERENCES:
patent: 7241606 (2007-07-01), Kubota et al.
patent: 7309696 (2007-12-01), Kucera et al.
patent: 2004/0247612 (2004-12-01), Wang
patent: 2005/0142132 (2005-06-01), Schenk et al.
patent: 1614695 (2006-01-01), None
patent: 9514805 (2005-02-01), None
patent: 9927944 (1999-06-01), None
patent: 0210361 (2002-02-01), None
patent: 02096350 (2002-12-01), None
patent: 03015812 (2003-02-01), None
patent: 03089460 (2003-10-01), None
patent: 2004087767 (2004-10-01), None
Janus C et al. Abeta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature, 2000; 408:979-982.
Morgan D et al. Abeta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature, 2000; 408:982-985.
Schenk D et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 1999; 400:173-177.
Solomon B. Immunological approaches as therapy for Alzheimer's disease. Expert Opin. Biol. Ther. 2002; 2(8):907-917.
Vickers JC. A vaccine against Alzheimer's disease: Developments to date. Drugs Aging. 2002; 19(7):487-494.
Agadjanyan et al., Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide, Journal Immunology, 174(3):1580-1586 (2005).
Singh et al., ProPred: prediction of HLA-DR binding sites, Bioinformatics, 17(12):1236-1237 (2001).
Yano, 9. Saibo Ketsugo Hairetsu o Mochiita Eki Kyushusei Peptide Seizai no Sekkei, Atarshii Iryo Kiki Kenkyu, 11:16 along with its excerpt translation (2006).
Yano et al., An ingenious design for peptide vaccines, Vaccine, 23:2322-2326 (2005).
M. Manea, et al., “Polypeptide Conjugates Comprising a β-Amyloid Plaque-Specific Epitope as New Vaccine Structures Against Alzheimer's Disease”, Biopolymers (Peptide Science), Jan. 1, 2004, p. 503-511, vol. 76, No. 6, Wiley Periodicals, Inc.
M. Maier, et al., “Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response”, The Journal of Neuroscience, May 3, 2006, p. 4717-4728, vol. 26, No. 18, Society of Neuroscience.
Miwa Yoshikatsu
Nishizawa Toshiki
Yano Akira
Ballard Kimberly A
Browdy and Neimark PLLC
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
Kemmerer Elizabeth C
LandOfFree
Peptide vaccine for inducing the production of anti-amyloid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide vaccine for inducing the production of anti-amyloid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide vaccine for inducing the production of anti-amyloid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4257633